Masimo Pre-Tax Profit Margin 2012-2025 | MASI
Current and historical pre-tax profit margin for Masimo (MASI) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Masimo pre-tax profit margin for the three months ending September 30, 2025 was .
| Masimo Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $2.18B | $-0.21B | -9.57% |
| 2025-06-30 | $2.15B | $-0.26B | -11.84% |
| 2025-03-31 | $2.13B | $-0.28B | -13.12% |
| 2024-12-31 | $2.10B | $-0.31B | -14.56% |
| 2024-09-30 | $1.58B | $0.13B | 7.93% |
| 2024-06-30 | $1.71B | $0.11B | 6.43% |
| 2024-03-31 | $1.82B | $0.10B | 5.70% |
| 2023-12-31 | $2.05B | $0.09B | 4.30% |
| 2023-09-30 | $2.12B | $0.12B | 5.72% |
| 2023-06-30 | $2.19B | $0.16B | 7.27% |
| 2023-03-31 | $2.30B | $0.16B | 7.01% |
| 2022-12-31 | $2.04B | $0.19B | 9.53% |
| 2022-09-30 | $1.75B | $0.22B | 12.31% |
| 2022-06-30 | $1.50B | $0.23B | 15.36% |
| 2022-03-31 | $1.24B | $0.27B | 21.62% |
| 2021-12-31 | $1.24B | $0.28B | 22.20% |
| 2021-09-30 | $1.21B | $0.27B | 21.97% |
| 2021-06-30 | $1.18B | $0.26B | 21.92% |
| 2021-03-31 | $1.17B | $0.26B | 21.91% |
| 2020-12-31 | $1.14B | $0.26B | 23.08% |
| 2020-09-30 | $1.10B | $0.26B | 23.79% |
| 2020-06-30 | $1.05B | $0.25B | 24.24% |
| 2020-03-31 | $0.98B | $0.25B | 25.18% |
| 2019-12-31 | $0.94B | $0.23B | 24.92% |
| 2019-09-30 | $0.91B | $0.23B | 24.73% |
| 2019-06-30 | $0.90B | $0.22B | 24.78% |
| 2019-03-31 | $0.88B | $0.22B | 24.94% |
| 2018-12-31 | $0.86B | $0.22B | 25.03% |
| 2018-09-30 | $0.84B | $0.20B | 24.17% |
| 2018-06-30 | $0.83B | $0.20B | 23.85% |
| 2018-03-31 | $0.81B | $0.19B | 23.33% |
| 2017-12-31 | $0.79B | $0.19B | 23.42% |
| 2017-09-30 | $0.78B | $0.46B | 59.13% |
| 2017-06-30 | $0.76B | $0.46B | 60.16% |
| 2017-03-31 | $0.74B | $0.45B | 60.76% |
| 2016-12-31 | $0.71B | $0.43B | 60.87% |
| 2016-09-30 | $0.68B | $0.15B | 21.50% |
| 2016-06-30 | $0.66B | $0.14B | 20.63% |
| 2016-03-31 | $0.65B | $0.13B | 19.63% |
| 2015-12-31 | $0.63B | $0.12B | 18.54% |
| 2015-09-30 | $0.63B | $0.11B | 18.05% |
| 2015-06-30 | $0.62B | $0.11B | 17.50% |
| 2015-03-31 | $0.60B | $0.10B | 16.61% |
| 2014-12-31 | $0.59B | $0.10B | 17.38% |
| 2014-09-30 | $0.57B | $0.08B | 14.64% |
| 2014-06-30 | $0.55B | $0.08B | 14.62% |
| 2014-03-31 | $0.55B | $0.09B | 15.45% |
| 2013-12-31 | $0.55B | $0.08B | 13.92% |
| 2013-09-30 | $0.54B | $0.09B | 15.86% |
| 2013-06-30 | $0.52B | $0.08B | 16.03% |
| 2013-03-31 | $0.51B | $0.08B | 16.27% |
| 2012-12-31 | $0.49B | $0.08B | 17.04% |
| 2012-09-30 | $0.47B | $0.08B | 17.55% |
| 2012-06-30 | $0.46B | $0.08B | 18.12% |
| 2012-03-31 | $0.45B | $0.08B | 18.88% |
| 2011-12-31 | $0.44B | $0.09B | 20.05% |
| 2011-09-30 | $0.43B | $0.09B | 20.79% |
| 2011-06-30 | $0.43B | $0.10B | 22.09% |
| 2011-03-31 | $0.42B | $0.09B | 22.14% |
| 2010-12-31 | $0.41B | $0.11B | 26.35% |
| 2010-09-30 | $0.39B | $0.11B | 26.97% |
| 2010-06-30 | $0.38B | $0.10B | 27.18% |
| 2010-03-31 | $0.36B | $0.10B | 28.10% |
| 2009-12-31 | $0.35B | $0.08B | 23.50% |
| 2009-09-30 | $0.34B | $0.08B | 23.89% |
| 2009-06-30 | $0.33B | $0.08B | 24.55% |
| 2009-03-31 | $0.32B | $0.08B | 24.30% |
| 2008-12-31 | $0.31B | $0.07B | 23.45% |
| 2008-09-30 | $0.29B | $0.07B | 23.89% |
| 2008-06-30 | $0.28B | $0.07B | 23.66% |
| 2008-03-31 | $0.27B | $0.07B | 25.00% |
| 2007-12-31 | $0.26B | $0.07B | 26.56% |
| 2007-09-30 | $0.25B | $0.07B | 28.98% |
| 2007-06-30 | $0.24B | $0.08B | 32.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.665B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.567B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $189.075B | 73.97 |
| IDEXX Laboratories (IDXX) | United States | $54.780B | 54.40 |
| Edwards Lifesciences (EW) | United States | $48.432B | 32.47 |
| IQVIA Holdings (IQV) | United States | $39.797B | 22.19 |
| Alcon (ALC) | Switzerland | $39.104B | 26.35 |
| Mettler-Toledo (MTD) | United States | $28.673B | 33.55 |
| DexCom (DXCM) | United States | $27.586B | 38.03 |
| STERIS (STE) | Ireland | $25.321B | 26.14 |
| Waters (WAT) | United States | $22.858B | 30.23 |
| Coloplast (CLPBY) | Denmark | $18.998B | 32.42 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.345B | 0.00 |
| Penumbra (PEN) | United States | $13.920B | 97.92 |
| Globus Medical (GMED) | United States | $12.440B | 26.11 |
| Glaukos (GKOS) | United States | $7.090B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.188B | 19.66 |
| TransMedics (TMDX) | United States | $4.850B | 57.46 |
| Teleflex (TFX) | United States | $4.434B | 7.07 |
| LivaNova (LIVN) | United Kingdom | $3.436B | 18.56 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Integer Holdings (ITGR) | United States | $2.984B | 14.01 |
| Alphatec Holdings (ATEC) | United States | $2.548B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.400B | 22.45 |
| Artivion (AORT) | United States | $2.061B | 94.59 |
| UFP Technologies (UFPT) | United States | $2.023B | 26.71 |
| Nihon Kohden (NHNKY) | Japan | $1.955B | 17.07 |
| PROCEPT BioRobotics (PRCT) | United States | $1.694B | 0.00 |
| AxoGen (AXGN) | United States | $1.470B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.389B | 0.00 |
| IRadimed (IRMD) | United States | $1.310B | 62.41 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.937B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.935B | 5.07 |
| Beta Bionics (BBNX) | United States | $0.811B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.671B | 38.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.550B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.548B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.540B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.463B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.458B | 12.63 |
| AngioDynamics (ANGO) | United States | $0.427B | 0.00 |
| RxSight (RXST) | United States | $0.397B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.360B | 59.94 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.237B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.195B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.143B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Neuronetics (STIM) | United States | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.126B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.092B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Venus Concept (VERO) | Canada | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.15 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |